Emerging Therapeutics From engineered cells to therapies that deliver
For leaders and operators turning breakthrough modalities into real patient impact.
CAR-T, TILs, NK, allogeneic + in vivo approaches, focused on what’s translating.
Checkpoint 2.0, vaccines, ADCs, combos, resistance, and biomarker gates.
mRNA/siRNA/ASOs, in vivo gene therapy, iPSC platforms, and patient stratification.
Why: Track Focus
The bottleneck isn’t “more modalities.” It’s translation: manufacturability, delivery, safety, and clinical proof that holds up.
- From breakthrough to scalable CMC, automation, supply chain, and repeatable manufacturing.
- From response to durability persistence, safety, resistance, and smart combinations.
- From patient promise to patient selection biomarkers, stratification, and clinical decision points.
Who: Attends
Key challenges we help you solve
Automation, CMC, consistency, cost, and supply chain realities.
TME barriers, trafficking, persistence, and on-target/off-tumor risk.
Control, conditioning, cytokine risk, and long-term response.
Who benefits, how to pick combos, and when to switch.
Site readiness, logistics, and operationalizing complex protocols.
Evidence expectations, evolving standards, and defensible strategy.
Therapeutics leaders
Track 1 speakers · March 4–6, 2026
Mar 4 — Next-Gen Tx
Mar 5 — Immunotherapies & Targeted Therapies
Mar 6 — Next-Gen Tx
Build therapies that actually translate
Register for the content, sponsor for the meetings.
There is no other event with such a lineup of leaders in their field. My annual MUST event since 2013!
Thomas Wilckens, MD, VP Precision Medicine & Precision Health, ECTT
You truly have an all-star, world-class crew lined up!
Alexis Hall, PhD, Professor
I am thrilled to hear about the impressive 2026 lineup of speakers and the engaging topics planned for the conference.
Amanda Acerbi, PharmD, Precision Medicine Global Director, Janssen (J&J)
PMWC is a landmark event, a real tour de force in precision medicine!
Mehme Hachem, PhD, Sr. Bioinformatician, IO / ML, Université de Montréal
The conference is excellent, and the 2026 speaker lineup is truly stellar — it seems to get stronger every year.
Mike Zack, MD, PhD, MPH, CEO & Co‑Founder, PGxAI
I just registered, fantastic lineup! Can't wait for this!
Thierry Giffon, PhD, Immunologist, Translational Scientific Leader
Congrats. This is an amazing rock star lineup.
Amanda Cashin, PhD, Bio Company Builder & Investor, Wing VC
The PMWC program and speaker lineup is one of the most impactful and thoughtfully curated conferences in healthcare today.
Tanmay Khilnani, Founder & Chief, Dept. of Medicine, University of Washington
I’ve spoken and had exhibitions in the past at PMWC — one of my favorite conferences of the year — and this 2026 year is extra impressive.
Tod Klingler, PhD, Co‑Founder & CEO, GeneLeap
Tal has done an amazing job developing the PMWC into the #1 premier precision medicine conference.
Trish Brown, SVP, Payer Relations and Reimbursement, GeneDx
Incredible line up! Great event you are putting on
Christina Zigliotto, Head of Generative AI & Machine Learning, Amazon AWS
What an impressive lineup.
I‑Chen Fong, PharmD, Ambulatory Care Pharmacist, Kaiser Permanente
Congratulations on the amazing speaker lineup this year. Wow!
Snehit Prabhu, PhD, Chief Data Scientist, Cancer Cell Therapy, Stanford Cancer Institute
PMWC 2025 was excellent, and the lineup sounds truly impressive!
Liat Dassa, PhD, Director of Program Planning, Biology & Computational Models, CytoReason
The line up has come together beautifully and quite impressively. Many people have mentioned how much they are looking forward to it.
Andrea Vuturo, Partner, Vuturo Group










































